These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 27863103)

  • 1. The Use of Molecular Oxygen in Pharmaceutical Manufacturing: Is Flow the Way to Go?
    Hone CA; Roberge DM; Kappe CO
    ChemSusChem; 2017 Jan; 10(1):32-41. PubMed ID: 27863103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Use of Molecular Oxygen for Liquid Phase Aerobic Oxidations in Continuous Flow.
    Hone CA; Kappe CO
    Top Curr Chem (Cham); 2018 Dec; 377(1):2. PubMed ID: 30536152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experimental Limiting Oxygen Concentrations for Nine Organic Solvents at Temperatures and Pressures Relevant to Aerobic Oxidations in the Pharmaceutical Industry.
    Osterberg PM; Niemeier JK; Welch CJ; Hawkins JM; Martinelli JR; Johnson TE; Root TW; Stahl SS
    Org Process Res Dev; 2015 Nov; 19(11):1537-1543. PubMed ID: 26622165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Continuous-flow technology—a tool for the safe manufacturing of active pharmaceutical ingredients.
    Gutmann B; Cantillo D; Kappe CO
    Angew Chem Int Ed Engl; 2015 Jun; 54(23):6688-728. PubMed ID: 25989203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic engineering: the ultimate paradigm for continuous pharmaceutical manufacturing.
    Yadav VG; Stephanopoulos G
    ChemSusChem; 2014 Jul; 7(7):1847-53. PubMed ID: 24719301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Active pharmaceutical ingredient (API) production involving continuous processes--a process system engineering (PSE)-assisted design framework.
    Cervera-Padrell AE; Skovby T; Kiil S; Gani R; Gernaey KV
    Eur J Pharm Biopharm; 2012 Oct; 82(2):437-56. PubMed ID: 22820647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Equipment and analytical companies meeting continuous challenges. May 20-21, 2014 Continuous Manufacturing Symposium.
    Page T; Dubina H; Fillipi G; Guidat R; Patnaik S; Poechlauer P; Shering P; Guinn M; Mcdonnell P; Johnston C
    J Pharm Sci; 2015 Mar; 104(3):821-31. PubMed ID: 25448273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Continuous low-dose feeding of highly active pharmaceutical ingredients in hot-melt extrusion.
    Llusa M; Mohr S; Baumgartner R; Paudel A; Koscher G; Khinast J
    Drug Dev Ind Pharm; 2016 Aug; 42(8):1360-4. PubMed ID: 26755129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Upflow anaerobic sludge blanket reactor--a review.
    Bal AS; Dhagat NN
    Indian J Environ Health; 2001 Apr; 43(2):1-82. PubMed ID: 12397675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Concept of Chemical Generators: On-Site On-Demand Production of Hazardous Reagents in Continuous Flow.
    Dallinger D; Gutmann B; Kappe CO
    Acc Chem Res; 2020 Jul; 53(7):1330-1341. PubMed ID: 32543830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The route from problem to solution in multistep continuous flow synthesis of pharmaceutical compounds.
    Bana P; Örkényi R; Lövei K; Lakó Á; Túrós GI; Éles J; Faigl F; Greiner I
    Bioorg Med Chem; 2017 Dec; 25(23):6180-6189. PubMed ID: 28087127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Catalytic enantioselective oxidations using molecular oxygen.
    Sigman MS; Jensen DR; Rajaram S
    Curr Opin Drug Discov Devel; 2002 Nov; 5(6):860-9. PubMed ID: 12478717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Continuous processes for the production of pharmaceutical intermediates and active pharmaceutical ingredients.
    LaPorte TL; Wang C
    Curr Opin Drug Discov Devel; 2007 Nov; 10(6):738-45. PubMed ID: 17987525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deciding whether to go with the flow: evaluating the merits of flow reactors for synthesis.
    Hartman RL; McMullen JP; Jensen KF
    Angew Chem Int Ed Engl; 2011 Aug; 50(33):7502-19. PubMed ID: 21710673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modeling the phase behavior in mixtures of pharmaceuticals with liquid or supercritical solvents.
    Tsivintzelis I; Economou IG; Kontogeorgis GM
    J Phys Chem B; 2009 May; 113(18):6446-58. PubMed ID: 19368360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biocatalysis in development of green pharmaceutical processes.
    Tao J; Xu JH
    Curr Opin Chem Biol; 2009 Feb; 13(1):43-50. PubMed ID: 19264533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Achieving continuous manufacturing: technologies and approaches for synthesis, workup, and isolation of drug substance. May 20-21, 2014 Continuous Manufacturing Symposium.
    Baxendale IR; Braatz RD; Hodnett BK; Jensen KF; Johnson MD; Sharratt P; Sherlock JP; Florence AJ
    J Pharm Sci; 2015 Mar; 104(3):781-91. PubMed ID: 25470351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced Ga2O3-photocatalyzed and photochemical degradation of the Fipronil insecticide by UVC irradiation in mixed aqueous/organic media under an inert atmosphere.
    Hidaka H; Tsukamoto T; Mitsutsuka Y; Oyama T; Serpone N
    Photochem Photobiol Sci; 2015 May; 14(5):919-28. PubMed ID: 25722187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of the solvation parameter model in method development for analysis of residual solvents in pharmaceuticals.
    Liu Y; Hu CQ
    J Chromatogr A; 2009 Jan; 1216(1):86-91. PubMed ID: 19041980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Future supply chains enabled by continuous processing--opportunities and challenges. May 20-21, 2014 Continuous Manufacturing Symposium.
    Srai JS; Badman C; Krumme M; Futran M; Johnston C
    J Pharm Sci; 2015 Mar; 104(3):840-9. PubMed ID: 25631279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.